Follow
Drug Resistance
Drug Resistance refers to microorganisms mutates and becomes insensitive to a drug that was previously effective. The term is used in the context of resistance that pathogens or cancers have "acquired", that is, resistance has evolved.
-
MAR 04, 2016Clinical & Molecular DX
A new small-molecule drug was recently shown to protect Rhesus monkeys from the Ebola virus, decreasing viral loads sign ...FEB 27, 2016Clinical & Molecular DX
Survival of the fittest has a generally positive connotation. After all, this evolutionary principle is the driving forc ...FEB 24, 2016Clinical & Molecular DX
Cancer cells are exquisitely cunning – they mutate and adapt to escape the body’s own defense mechanisms, an ...FEB 10, 2016Chemistry & Physics
Screening large “libraries” of compounds to find those with a desired biological activity is a powerful meth ...Written By: The Scripps Research Institute (TSRI)FEB 09, 2016Health & Medicine
Obesity, diabetes, and other metabolic conditions are a huge problem for which there is not yet an effective solution. A ...Written By: Cassidy ReichFEB 05, 2016Health & Medicine
Depression affects millions of Americans and many of those people are taking some kind of medication. Selective se ...Written By: Cassidy ReichFEB 04, 2016Cancer
Cancer cells rarely spread on their own, preferring to travel in groups from their original tumor site, a new study with ...Written By: Futurity (futurity.org)FEB 02, 2016Cell & Molecular Biology
A team led by scientists at The Scripps Research Institute (TSRI) has solved a long-standing mystery in cell biology by ...Written By: The Scripps Research Institute (TSRI)FEB 01, 2016Microbiology
To most of us “virulent” means “aggressive,” or just plain “bad,” but to a microbiol ...Written By: Futurity (futurity.org)JAN 23, 2016Chemistry & Physics
‘Strain-release amination’ technique emerged from efforts to help Pfizer synthesize promising cancer drug ca ...Written By: The Scripps Research Institute (TSRI)JAN 19, 2016Cancer
Packaging a cancer drug in bubble containers derived from a patient’s own immune system makes it much more ef ...Written By: Futurity (futurity.org)DEC 28, 2015Cannabis Sciences
Almost one-third of epilepsy patients suffer from a treatment-resistant form. Their condition is associated with severe ...Written By: Julianne ChiaetDEC 26, 2015Clinical & Molecular DX
Bacterial biofilms are among the biggest scourges in hospitals, causing infections that are difficult to treat because m ...DEC 19, 2015Cardiology
Manipulating the activity of the gut microbiome has been linked to reducing the risk for cardiovascular disease like str ...Written By: Kara MarkerDEC 08, 2015Clinical & Molecular DX
Scientists from The Scripps Research Institute (TSRI) have deployed a powerful new drug discovery technique to identify ...Written By: The Scripps Research Institute (TSRI)NOV 29, 2015Clinical & Molecular DX
Researchers at Sanford Burnham Prebys Medical Discovery Institute announced the discovery of a new anti-cancer compound, ...NOV 28, 2015Clinical & Molecular DX
Doctors at the University of Montreal Hospital Research Centre (CRCHUM) have announced the start of a Phase 3 clinical t ...NOV 19, 2015Immunology
Small cell lung cancer (SCLC) has a long history of evading both the immune system and scientists trying to study how it ...Written By: Kara MarkerNOV 17, 2015Microbiology
Tuberculosis has been infecting humans for several millennia, making it one of the most horribly successful diseases in ...Written By: The Scripps Research Institute (TSRI)NOV 01, 2015Clinical & Molecular DX
Gene-targeted and personalized therapy currently exists for a small handful of diseases, but that list may soon include ...OCT 29, 2015Microbiology
The problem with antibiotics is that bacteria become resistant. Researchers at the University of Illinois at Urban ...Written By: Kerry EvansOCT 26, 2015Immunology
Sirolimus, an immunosuppressant drug, as recently been used in clinical trials for patients with autoimmune blood disord ...Written By: Kara MarkerOCT 02, 2015Microbiology
A research team at Merck (accidentally) uncovered a new antibacterial target - a riboswitch important for riboflavin (vi ...Written By: Kerry EvansSEP 29, 2015Cancer
UC San Francisco scientists have developed a molecular “on switch” enabling tight control over the acti ...Written By: Ilene Schneider
MAR 04, 2016
Clinical & Molecular DX
A new small-molecule drug was recently shown to protect Rhesus monkeys from the Ebola virus, decreasing viral loads sign
...
FEB 27, 2016
Clinical & Molecular DX
Survival of the fittest has a generally positive connotation. After all, this evolutionary principle is the driving forc
...
FEB 24, 2016
Clinical & Molecular DX
Cancer cells are exquisitely cunning – they mutate and adapt to escape the body’s own defense mechanisms, an
...
FEB 10, 2016
Chemistry & Physics
Screening large “libraries” of compounds to find those with a desired biological activity is a powerful meth
...
Written By:
The Scripps Research Institute (TSRI)
FEB 09, 2016
Health & Medicine
Obesity, diabetes, and other metabolic conditions are a huge problem for which there is not yet an effective solution. A
...
Written By:
Cassidy Reich
FEB 05, 2016
Health & Medicine
Depression affects millions of Americans and many of those people are taking some kind of medication. Selective se
...
Written By:
Cassidy Reich
FEB 04, 2016
Cancer
Cancer cells rarely spread on their own, preferring to travel in groups from their original tumor site, a new study with
...
Written By:
Futurity (futurity.org)
FEB 02, 2016
Cell & Molecular Biology
A team led by scientists at The Scripps Research Institute (TSRI) has solved a long-standing mystery in cell biology by
...
Written By:
The Scripps Research Institute (TSRI)
FEB 01, 2016
Microbiology
To most of us “virulent” means “aggressive,” or just plain “bad,” but to a microbiol
...
Written By:
Futurity (futurity.org)
JAN 23, 2016
Chemistry & Physics
‘Strain-release amination’ technique emerged from efforts to help Pfizer synthesize promising cancer drug ca
...
Written By:
The Scripps Research Institute (TSRI)
JAN 19, 2016
Cancer
Packaging a cancer drug in bubble containers derived from a patient’s own immune system makes it much more ef
...
Written By:
Futurity (futurity.org)
DEC 28, 2015
Cannabis Sciences
Almost one-third of epilepsy patients suffer from a treatment-resistant form. Their condition is associated with severe
...
Written By:
Julianne Chiaet
DEC 26, 2015
Clinical & Molecular DX
Bacterial biofilms are among the biggest scourges in hospitals, causing infections that are difficult to treat because m
...
DEC 19, 2015
Cardiology
Manipulating the activity of the gut microbiome has been linked to reducing the risk for cardiovascular disease like str
...
Written By:
Kara Marker
DEC 08, 2015
Clinical & Molecular DX
Scientists from The Scripps Research Institute (TSRI) have deployed a powerful new drug discovery technique to identify
...
Written By:
The Scripps Research Institute (TSRI)
NOV 29, 2015
Clinical & Molecular DX
Researchers at Sanford Burnham Prebys Medical Discovery Institute announced the discovery of a new anti-cancer compound,
...
NOV 28, 2015
Clinical & Molecular DX
Doctors at the University of Montreal Hospital Research Centre (CRCHUM) have announced the start of a Phase 3 clinical t
...
NOV 19, 2015
Immunology
Small cell lung cancer (SCLC) has a long history of evading both the immune system and scientists trying to study how it
...
Written By:
Kara Marker
NOV 17, 2015
Microbiology
Tuberculosis has been infecting humans for several millennia, making it one of the most horribly successful diseases in
...
Written By:
The Scripps Research Institute (TSRI)
NOV 01, 2015
Clinical & Molecular DX
Gene-targeted and personalized therapy currently exists for a small handful of diseases, but that list may soon include
...
OCT 29, 2015
Microbiology
The problem with antibiotics is that bacteria become resistant. Researchers at the University of Illinois at Urban
...
Written By:
Kerry Evans
OCT 26, 2015
Immunology
Sirolimus, an immunosuppressant drug, as recently been used in clinical trials for patients with autoimmune blood disord
...
Written By:
Kara Marker
OCT 02, 2015
Microbiology
A research team at Merck (accidentally) uncovered a new antibacterial target - a riboswitch important for riboflavin (vi
...
Written By:
Kerry Evans
SEP 29, 2015
Cancer
UC San Francisco scientists have developed a molecular “on switch” enabling tight control over the acti
...
Written By:
Ilene Schneider